Brain tumors and syndromes in children

Neuropediatrics

Volumn 45, Issue 3, 2014, Pages 137-161

  Bleeker, Fonnet E ^a   Hopman, Saskia M J ^a   Merks, Johannes H M ^a   Aalfs, Cora M ^a   Hennekam, Raoul C M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

brain tumor; child; gene; genetic; infant; malformation; surveillance; syndrome

Indexed keywords

APC PROTEIN; ATM PROTEIN; B RAF KINASE; BRG1 PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1C; CYCLIN DEPENDENT KINASE INHIBITOR 2A; E1A ASSOCIATED P300 PROTEIN; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP C PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP E PROTEIN; FANCONI ANEMIA GROUP F PROTEIN; FANCONI ANEMIA GROUP G PROTEIN; FANCONI ANEMIA GROUP L PROTEIN; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FRAGILE X MENTAL RETARDATION PROTEIN; ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE 2; K RAS PROTEIN; MISMATCH REPAIR PROTEIN PMS2; NEUROFIBROMIN; NIBRIN; PROTEIN MLH1; PROTEIN MSH6; PROTEIN P53; PROTEIN PATCHED 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; RAD50 PROTEIN; SOS PROTEIN;

ACROCEPHALOSYNDACTYLY; AICARDI SYNDROME; ALBRIGHT SYNDROME; ANOPHTHALMIA; ASTROCYTOMA; ATAXIA TELANGIECTASIA; BASAL CELL NEVUS SYNDROME; BECKWITH WIEDEMANN SYNDROME; BLOOM SYNDROME; BLUE RUBBER BLEB NEVUS; BRAIN TUMOR; CALCIFYING CHONDRODYSTROPHY; CARNEY COMPLEX; CHILDHOOD DISEASE; CHOROID PLEXUS PAPILLOMA; CHOROID PLEXUS TUMOR; CHROMOSOMAL INSTABILITY; COFFIN LOWRY SYNDROME; CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME; COSTELLO SYNDROME; COWDEN SYNDROME; CRANIOPHARYNGIOMA; DOWN SYNDROME; DYSPLASTIC NEVUS; EARLY DIAGNOSIS; ENCEPHALOCELE; ENCHONDROMATOSIS; EPENDYMOMA; FAMILIAL CANCER; FAMILIAL COLON POLYPOSIS; FANCONI ANEMIA; FRAGILE X SYNDROME; GENETIC DISORDER; GERM CELL TUMOR; GERMLINE MUTATION; GLIOBLASTOMA; GLIOMA; HEMANGIOBLASTOMA; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; HYPOPHYSIS ADENOMA; HYPOPIGMENTATION; IRIS COLOBOMA; KIDNEY AGENESIS; KLINEFELTER SYNDROME; MEDULLOBLASTOMA; MELANOMA; MENINGIOMA; MENTAL DEFICIENCY; MICROPHTHALMIA; MISMATCH REPAIR; MOLECULAR DIAGNOSIS; MORNING GLORY SYNDROME; MULTIPLE ACYL COA DEHYDROGENASE DEFICIENCY; MULTIPLE ENDOCRINE NEOPLASIA; NEUROBLASTOMA; NEUROFIBROMATOSIS; NIJMEGEN BREAKAGE SYNDROME; NONHUMAN; NOONAN SYNDROME; OBESITY; OLIGODENDROGLIOMA; ONCOGENE H RAS; ORBIT CYST; OSTEOCHONDROMA; PALLISTER HALL SYNDROME; PERIPHERAL NEUROPATHY; PEUTZ JEGHERS SYNDROME; PHELAN MCDERMID SYNDROME; PIERPONT SYNDROME; POLYDACTYLY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHABDOID TUMOR; RUBINSTEIN SYNDROME; SCHINZEL GIEDION SYNDROME; SCHWANNOMATOSIS; SHORT STATURE; SILVER RUSSELL SYNDROME; SMITH LEMLI OPITZ SYNDROME; SOMATIC MUTATION; SYNDROME; TERATOMA; TUBEROUS SCLEROSIS COMPLEX; TUMOR DIAGNOSIS; TUMOR PREDISPOSITION SYNDROME; TURCOT SYNDROME; TURNER SYNDROME; VON HIPPEL LINDAU DISEASE; CHILD; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD;

BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; SYNDROME;

EID: 84901811493     PISSN: 0174304X     EISSN: 14391899     Source Type: Journal    
DOI: 10.1055/s-0034-1368116     Document Type: Review

References (91)

1. Vogelstein B., Kinzler K. W. The Genetic Basis of Human Cancer. 2nd ed. New York, NY McGraw-Hill: 2002
2. Fleming A. J., Chi S. N. Brain tumors in children. Curr Probl Pediatr Adolesc Health Care: 2012; 42 4 80 103
3. Garber J. E., Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol: 2005; 23 2 276 292
4. Ponder B. A. Cancer genetics. Nature: 2001; 411 6835 336 341
5. Knudson A. G. Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A: 1971; 68 4 820 823
6. Foulkes W. D. Inherited susceptibility to common cancers. N Engl J Med: 2008; 359 20 2143 2153
7. Eng C., Ponder B. A. The role of gene mutations in the genesis of familial cancers. FASEB J: 1993; 7 10 910 919
8. Hennekam R. CM, Allanson J. E., Krantz I. D. Gorlin's Syndromes of the Head and Neck. 5th ed. New York, NY Oxford University Press Inc.: 2010
9. Agha M. M., Williams J. I., Marrett L., To T., Zipursky A., Dodds L. Congenital abnormalities and childhood cancer. Cancer: 2005; 103 9 1939 1948
10. Altmann A. E., Halliday J. L., Giles G. G. Associations between congenital malformations and childhood cancer. A register-based case-control study. Br J Cancer: 1998; 78 9 1244 1249
11. Merks J. H., Ozgen H. M., Koster J., Zwinderman A. H., Caron H. N., Hennekam R. C. Prevalence and patterns of morphological abnormalities in patients with childhood cancer. JAMA: 2008; 299 1 61 69
12. Merks J. H., Caron H. N., Hennekam R. C. High incidence of malformation syndromes in a series of 1,073 children with cancer. Am J Med Genet A: 2005; 134A 2 132 143
13. Bourdeaut F., Lequin D., Brugières L., et al. Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor. Clin Cancer Res: 2011; 17 1 31 38
14. Merks J. H., Ozgen H. M., Cluitmans T. L., et al. Normal values for morphological abnormalities in school children. Am J Med Genet A: 2006; 140 19 2091 2109
15. Dolecek T. A., Propp J. M., Stroup N. E., Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro-oncol: 2012; 14 05 v1 v49
16. Howlader N., Noone A. M., Krapcho M., et al. SEER Cancer Statistics Review, 1975-2010. National Cancer Institute. Available at: http://seer.cancer. gov/csr/1975-2010/ based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
17. Kieran M. W., Walker D., Frappaz D., Prados M. Brain tumors: from childhood through adolescence into adulthood. J Clin Oncol: 2010; 28 32 4783 4789
18. Semerci C. N., Bebitoglu I., Kaçar A., et al. An unusual fetus with complete absence of thoracic, lumbar and sacral vertebrae, bilateral renal agenesis, VSD, meningomyelocele, imperforate anus, and teratoma. Clin Dysmorphol: 2001; 10 1 57 60
19. Blount J. P., Elton S. Spinal lipomas. Neurosurg Focus: 2001; 10 1 e3
20. Goyal N., Singh P. K., Kakkar A., Sharma M. C., Mahapatra A. K. Mature teratoma in association with neural tube defect (occipital encephalocele): series of four cases and review of the literature. Pediatr Neurosurg: 2012; 48 2 67 72
21. Villavicencio E. H., Walterhouse D. O., Iannaccone P. M. The sonic hedgehog-patched-gli pathway in human development and disease. Am J Hum Genet: 2000; 67 5 1047 1054
22. Poduri A., Evrony G. D., Cai X., Walsh C. A. Somatic mutation, genomic variation, and neurological disease. Science: 2013; 341 6141 1237758
23. Winter R. M., Baraitser M. The London Dysmorphology Database. J Med Genet: 1987; 24 8 509 510
24. Louis D. N., Ohgaki H. WHO Classification of Tumours of the Central Nervous System. Lyon, France IARC Press: 2007
25. Hopman S. M., Merks J. H., de Borgie C. A., et al. The development of a clinical screening instrument for tumour predisposition syndromes in childhood cancer patients. Eur J Cancer: 2013; 49 15 3247 3254
26. Steliarova-Foucher E., Stiller C., Lacour B., Kaatsch P. International classification of childhood cancer, third edition. Cancer: 2005; 103 1457 1467
27. Lubs M. L., Bauer M. S., Formas M. E., Djokic B. Lisch nodules in neurofibromatosis type 1. N Engl J Med: 1991; 324 18 1264 1266
28. Carli M., Ferrari A., Mattke A., et al. Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group. J Clin Oncol: 2005; 23 33 8422 8430
29. Porter D. E., Prasad V., Foster L., Dall G. F., Birch R., Grimer R. J. Survival in Malignant Peripheral Nerve Sheath Tumours: A Comparison between Sporadic and Neurofibromatosis Type 1-Associated Tumours. Sarcoma: 2009; 2009 756395
30. Wilding A., Ingham S. L., Lalloo F., et al. Life expectancy in hereditary cancer predisposing diseases: an observational study. J Med Genet: 2012; 49 4 264 269
31. Ruggieri M., Iannetti P., Polizzi A., et al. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients. Neuropediatrics: 2005; 36 1 21 34
32. Evans D. G., Birch J. M., Ramsden R. T. Paediatric presentation of type 2 neurofibromatosis. Arch Dis Child: 1999; 81 6 496 499
33. Asthagiri A. R., Parry D. M., Butman J. A., et al. Neurofibromatosis type 2. Lancet: 2009; 373 9679 1974 1986
34. Evans D. G. Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]. [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II] Genet Med: 2009; 11 9 599 610
35. Baser M. E., Friedman J. M., Aeschliman D., et al. Predictors of the risk of mortality in neurofibromatosis 2. Am J Hum Genet: 2002; 71 4 715 723
36. De Amorim Bernstein K., Sethi R., Trofimov A., et al. Early clinical outcomes using proton radiation for children with central nervous system atypical teratoid rhabdoid tumors. Int J Radiat Oncol Biol Phys: 2013; 86 1 114 120
37. Hasselblatt M., Gesk S., Oyen F., et al. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. Am J Surg Pathol: 2011; 35 6 933 935
38. Sévenet N., Sheridan E., Amram D., Schneider P., Handgretinger R., Delattre O. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet: 1999; 65 5 1342 1348
39. Gessi M., Giangaspero F., Pietsch T. Atypical teratoid/rhabdoid tumors and choroid plexus tumors: when genetics surprise pathology. Brain Pathol: 2003; 13 3 409 414
40. Hulsebos T. J., Plomp A. S., Wolterman R. A., Robanus-Maandag E. C., Baas F., Wesseling P. Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet: 2007; 80 4 805 810
41. Plotkin S. R., Blakeley J. O., Evans D. G., et al. Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria. Am J Med Genet A: 2013; 161A 3 405 416
42. MacCollin M., Chiocca E. A., Evans D. G., et al. Diagnostic criteria for schwannomatosis. Neurology: 2005; 64 11 1838 1845
43. van den Munckhof P., Christiaans I., Kenter S. B., Baas F., Hulsebos T. J. Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri. Neurogenetics: 2012; 13 1 1 7
44. Tsurusaki Y., Okamoto N., Ohashi H., et al. Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. Nat Genet: 2012; 44 4 376 378
45. Santen G. WE, Aten E., Vulto-van Silfhout A. T., et al. Coffin-Siris consortium. Coffin-Siris syndrome and the BAF complex: genotype-phenotype study in 63 patients. Hum Mutat: 2013; 34 11 1519 1528
46. Kanno H., Kuratsu J., Nishikawa R., et al. Clinical features of patients bearing central nervous system hemangioblastoma in von Hippel-Lindau disease. Acta Neurochir (Wien): 2013; 155 1 1 7
47. Ahlsén G., Gillberg I. C., Lindblom R., Gillberg C. Tuberous sclerosis in Western Sweden. A population study of cases with early childhood onset. Arch Neurol: 1994; 51 1 76 81
48. Ichikawa T., Wakisaka A., Daido S., et al. A case of solitary subependymal giant cell astrocytoma: two somatic hits of TSC2 in the tumor, without evidence of somatic mosaicism. J Mol Diagn: 2005; 7 4 544 549
49. Russell-Swetek A., West A. N., Mintern J. E., et al. Identification of a novel TP53 germline mutation E285V in a rare case of paediatric adrenocortical carcinoma and choroid plexus carcinoma. J Med Genet: 2008; 45 9 603 606
50. Schniederjan M. J., Shehata B., Brat D. J., Esiashvili N., Janss A. J. De novo germline TP53 mutation presenting with synchronous malignancies of the central nervous system. Pediatr Blood Cancer: 2009; 53 7 1352 1354
51. Rausch T., Jones D. T., Zapatka M., et al. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell: 2012; 148 1-2 59 71
52. Zhukova N., Ramaswamy V., Remke M., et al. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol: 2013; 31 23 2927 2935
53. Villani A., Tabori U., Schiffman J., et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncol: 2011; 12 6 559 567
54. Garrè M. L., Cama A., Bagnasco F., et al. Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome-a new clinical perspective. Clin Cancer Res: 2009; 15 7 2463 2471
55. Brugières L., Remenieras A., Pierron G., et al. High frequency of germline SUFU mutations in children with desmoplastic/nodular medulloblastoma younger than 3 years of age. J Clin Oncol: 2012; 30 17 2087 2093
56. Merks J. H., de Vries L. S., Zhou X. P., et al. PTEN hamartoma tumour syndrome: variability of an entity. J Med Genet: 2003; 40 10 e111
57. Turcot J., Despres J. P., St Pierre F. Malignant tumors of the central nervous system associated with familial polyposis of the colon: report of two cases. Dis Colon Rectum: 1959; 2 465 468
58. Hamilton S. R., Liu B., Parsons R. E., et al. The molecular basis of Turcot's syndrome. N Engl J Med: 1995; 332 13 839 847
59. Schulmann K., Brasch F. E., Kunstmann E., et al. German HNPCC Consortium. HNPCC-associated small bowel cancer: clinical and molecular characteristics. Gastroenterology: 2005; 128 3 590 599
60. Merlo A., Rochlitz C., Scott R. Survival of patients with Turcot's syndrome and glioblastoma. N Engl J Med: 1996; 334 11 736 737
61. Vasen H. F., Sanders E. A., Taal B. G., et al. The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC). Int J Cancer: 1996; 65 4 422 425
62. Wimmer K., Etzler J. Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? Hum Genet: 2008; 124 2 105 122
63. Tan T. Y., Orme L. M., Lynch E., et al. Biallelic PMS2 mutations and a distinctive childhood cancer syndrome. J Pediatr Hematol Oncol: 2008; 30 3 254 257
64. Krüger S., Kinzel M., Walldorf C., et al. Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1. Eur J Hum Genet: 2008; 16 1 62 72
65. Van Meir E. G. Turcot's syndrome: phenotype of brain tumors, survival and mode of inheritance. Int J Cancer: 1998; 75 1 162 164
66. Nishisho I., Nakamura Y., Miyoshi Y., et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science: 1991; 253 5020 665 669
67. Gardner E. J. Follow-up study of a family group exhibiting dominant inheritance for a syndrome including intestinal polyps, osteomas, fibromas and epidermal cysts. Am J Hum Genet: 1962; 14 376 390
68. Bozbuga M., Turan Suslu H., Hicdonmez T., Bayindir C. Primary cerebellopontine angle craniopharyngioma in a patient with Gardner syndrome. J Clin Neurosci: 2011; 18 2 300 301
69. Kenning T. J., Kanwar V. S., Qian J., Deshaies E. M. A de novo desmoid tumor of the surgical site following foramen magnum meningioma resection in a patient with Gardner's Syndrome: a case report and review of the literature. J Neurooncol: 2009; 91 1 107 111
70. Leblanc R. Familial adenomatous polyposis and benign intracranial tumors: a new variant of Gardner's syndrome. Can J Neurol Sci: 2000; 27 4 341 346
71. D'Orazio J. A. Inherited cancer syndromes in children and young adults. J Pediatr Hematol Oncol: 2010; 32 3 195 228
72. Knapke S., Nagarajan R., Correll J., Kent D., Burns K. Hereditary cancer risk assessment in a pediatric oncology follow-up clinic. Pediatr Blood Cancer: 2012; 58 1 85 89
73. Méhes K. Malformations in children with cancer. Am J Med Genet A: 2006; 140 8 932
74. Lindhurst M. J., Sapp J. C., Teer J. K., et al. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med: 2011; 365 7 611 619
75. Huisman S. A., Redeker E. J., Maas S. M., Mannens M. M., Hennekam R. C. High rate of mosaicism in individuals with Cornelia de Lange syndrome. J Med Genet: 2013; 50 5 339 344
76. Listernick R., Mancini A. J., Charrow J. Segmental neurofibromatosis in childhood. Am J Med Genet A: 2003; 121A 2 132 135
77. Evans D. G., Ramsden R. T., Shenton A., et al. Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification. J Med Genet: 2007; 44 7 424 428
78. Aavikko M., Li S. P., Saarinen S., et al. Loss of SUFU function in familial multiple meningioma. Am J Hum Genet: 2012; 91 3 520 526
79. Zhang J., Wu G., Miller C. P., et al. St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project. Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet: 2013; 45 6 602 612
80. Rogers L., Pattisapu J., Smith R. R., Parker P. Medulloblastoma in association with the Coffin-Siris syndrome. Childs Nerv Syst: 1988; 4 1 41 44
81. Wilhelm H. Primary optic nerve tumours. Curr Opin Neurol: 2009; 22 1 11 18
82. Distel L., Neubauer S., Varon R., Holter W., Grabenbauer G. Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome. Med Pediatr Oncol: 2003; 41 1 44 48
83. Schiffman J. D., Geller J. I., Mundt E., Means A., Means L., Means V. Update on pediatric cancer predisposition syndromes. Pediatr Blood Cancer: 2013; 60 8 1247 1252
84. Alexandrov L. B., Nik-Zainal S., Wedge D. C., et al. Australian Pancreatic Cancer Genome Initiative; ICGC Breast Cancer Consortium; ICGC MMML-Seq Consortium; ICGC PedBrain. Signatures of mutational processes in human cancer. Nature: 2013; 500 7463 415 421
85. Bombard Y., Robson M., Offit K. Revealing the incidentalome when targeting the tumor genome. JAMA: 2013; 310 8 795 796
86. Cassidy S. B., Allanson J. E. Management of Genetic Syndromes. 3rd ed. Hoboken, NJ Wiley-Blackwell: 2010
87. Ullrich N. J. Inherited disorders as a risk factor and predictor of neurodevelopmental outcome in pediatric cancer. Dev Disabil Res Rev: 2008; 14 3 229 237
88. Kim A., Gillespie A., Dombi E., et al. Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas. Neurology: 2009; 73 16 1273 1279
89. Mautner V. F., Nguyen R., Kutta H., et al. Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2. Neuro-oncol: 2010; 12 1 14 18
90. Jóźwiak S., Nabbout R., Curatolo P.; participants of the TSC Consensus Meeting for SEGA and Epilepsy Management. Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations. Eur J Paediatr Neurol: 2013; 17 4 348 352
91. Hennekam R. C., Biesecker L. G., Allanson J. E., et al. Elements of Morphology Consortium. Elements of morphology: general terms for congenital anomalies. Am J Med Genet A: 2013; 161A 11 2726 2733